89
Views
4
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Increased serum CA125 II, but not CEA,CA19-9,AFP or CA72-4 in colon cancer compared to rectal cancer

, , , &
Pages 218-220 | Received 27 Nov 2020, Accepted 21 Dec 2020, Published online: 12 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tong Liu, Yao Jin, Xu Yang, Zhiqiang Tong & Mei Dong. (2023) The incidence rate of allergic reactions induced by oxaliplatin is higher in patients with rectal cancer compared with colon cancer. Drug and Chemical Toxicology 0:0, pages 1-7.
Read now
G Orchard, A Rhodes & NW Brown. (2021) British Journal of Biomedical Science in 2021. What have we learned?. British Journal of Biomedical Science 78:4, pages 159-166.
Read now

Articles from other publishers (2)

Rui Feng, De-Xin Cheng, Xiao-Chen Chen, Liu Yang & Hao Wu. (2023) Application of sintilimab combined with anlotinib hydrochloride in the clinical treatment of microsatellite stable colorectal cancer. World Journal of Gastrointestinal Oncology 15:11, pages 1925-1935.
Crossref
Han-Lu Gao, Le-Bin Lv, Wang-Fang Zhao, Qi-Wen Lu & Jin-Qing Fan. (2023) Diagnostic accuracy of the multi-target stool DNA test in detecting colorectal cancer: A hospital-based study. World Journal of Gastrointestinal Oncology 15:1, pages 102-111.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.